Registry following medical care of people with moderate-to-severe atopic dermatitis in Switzerland
Records how people with moderate-to-severe atopic dermatitis are treated in everyday care.
Plain-language title generated from the registry record
Registry title: Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland
Key facts
- Where
- Basel, Bern, Buochs, Fribourg, Lausanne, Lucerne, Sankt Gallen, Uster, and Zurich, SwitzerlandSee the 9 sites
Where in Switzerland
- Universitätsspital Basel, AllergologieBasel, SwitzerlandTaking people
- Inselspital, Department of DermatologyBern, SwitzerlandTaking people
- Dermatology & Skin Care ClinicBuochs, SwitzerlandTaking people
- HFR Hôpital Cantonal de FribourgFribourg, SwitzerlandTaking people
- Dermatologie CHUVLausanne, SwitzerlandTaking people
- Luzerner Kantonsspital, Zentrum für Dermatologie und AllergologieLucerne, SwitzerlandNot yet recruiting
- Kantonsspital St. Gallen - Klinik für Dermatologie, Venerologie und AllergologieSankt Gallen, SwitzerlandTaking people
- PLAZA KlinikenUster, SwitzerlandTaking people
- Institut für Dermatologie und Venerologie Stadtspital Zürich EuropaalleeZurich, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Swiss Society of Dermatology and Venereology
- Trial code
- NCT05819463
- Record updated
- 30 April 2025
- Original description
As structured and detailed data on the management of AD, a common chronic inflammatory skin disease which has a high impact on patients' quality of life and socioeconomic burden, are not available in Switzerland, the planned registry will overcome this gap. It will provide data on the medical care of patients with AD for health care research and allow to study the efficacy and safety of approved and available therapies for AD in daily life.Read full original descriptionShow less
Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - Swiss National Clinical Registry TREATswitzerland
As structured and detailed data on the management of AD, a common chronic inflammatory skin disease which has a high impact on patients' quality of life and socioeconomic burden, are not available in Switzerland, the planned registry will overcome this gap. It will provide data on the medical care of patients with AD for health care research and allow to study the efficacy and safety of approved and available therapies for AD in daily life.
Inclusion: Age ≥ 12 years; AD according to the UK Working Party's Diagnostic Criteria (28); Moderate to severe AD as defined by; objective SCORAD > 20 or IGA ≥ 3 (moderate) or; currently on systemic antiinflammatory therapy for AD or; previous systemic antiinflammatory therapy for AD within past 24 months.
Exclusion: refusal to sign the informed consent form.